Posted on 7440
Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing.
This financing brings the total capital raised to date to approximately £33 million (c. $45 million). The financing was led by existing shareholder The Baupost Group, with participation from existing investors including LifeForce Capital and new investors including Schooner Capital and Industry Ventures.
Dr. Samuel Cohen, Chief Executive Officer of Wren, commented: “This support from both our existing as well as our new shareholders will accelerate the advancement of our two lead small molecule programs towards the clinic for the potential treatment of Alzheimer’s disease and various synucleinopathies including Parkinson’s disease.”
Press release content from Business Wire. The AP news staff was not involved in its creation.
Wren Therapeutics Announces Financing of £12.4 Million (c. $17.0 Million)
January 25, 2021 GMT
CAMBRIDGE, United Kingdom (BUSINESS WIRE) Jan 25, 2021
Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing.
This financing brings the total capital raised to date to approximately £33 million (c. $45 million). The financing was led by existing shareholder The Baupost Group, with participation from existing investors including LifeForce Capital and new investors including Schooner Capital and Industry Ventures.
Celebrating love for a lifetime
Ruth and Paul SoRelle met as journalism students working at The Daily Texan.
“I was on the copydesk, and he came in (to the newsroom) to schmooze with the copy chief,” Ruth recalled. “Paul was (still in school) and also with the Long News Service covering the Legislature. I remember he had on a suit – an usual form of dress in the late 1960s.”
Initially friends, they started dating and eventually announced their marriage engagement to their families, which prompted a “heated discussion on the wedding and arrangements,” Paul said.
“We decided that we just wanted to get married, so we got a license and arranged for a Travis County judge to marry us,” Paul said. “I let my roommates know that we were going to wed. They put the announcement on the blackboard in The Daily Texan office. On April 10, 1970, we ended up having one of the largest elopements that spring at the Travis County Courthouse.”
Researchers identify genetic risk factors contributing to pneumonia susceptibility and severity
Researchers at Vanderbilt University Medical Center and colleagues have identified genetic factors that increase the risk for developing pneumonia and its severe, life-threatening consequences.
Their findings, published recently in the
American Journal of Human Genetics, may aid efforts to identify patients with COVID-19 at greatest risk for pneumonia, and enable earlier interventions to prevent severe illness and death.
Despite the increasing availability of COVID-19 vaccines, it will take months to inoculate enough people to bring the pandemic under control, experts predict. In the meantime, thousands of Americans are hospitalized and die from COVID-19 each day.